The Specialty News
Trading

Anthropic Ends Its Nasdaq Debut Up 17%, After Briefly Topping $2 Trillion

Priced at $83 the night before, ANT opened at $111.50, touched $114.99 and closed its first session at $97.17.

By The Specialty News DeskEdited by 4 min read
Anthropic Ends Its Nasdaq Debut Up 17%, After Briefly Topping $2 Trillion
Photo: TechCrunch / Wikimedia Commons (CC BY 2.0)

Anthropic's first public share changed hands at $111.50 on Thursday, $28.50 above the $83 price set the night before. At its high of $114.99 the stock briefly valued the maker of Claude at more than $2 trillion. It closed at $97.17, 17% above the offer, so the investors who bought in at $83, retail buyers among them, ended day one ahead.

From $83 to $111.50 at the First Trade

The opening price capped a week in which Anthropic raised its range, added 155 million shares and still drew more orders than it could fill. The $81.3 billion sale is the largest IPO on record, ahead of the roughly $75 billion SpaceX raised in June.

The stock pushed as high as $114.99 before giving back part of the move. It slid to a low of $92.72 on a day the Nasdaq 100 fell 2.2%, then recovered to close at $97.17, 17% above the offer price. Part of the selling was planned: up to 315 million shares held by employees and other non-founder insiders could be sold from the first day, under the terms set out in the filing.

Many of those buyers were ordinary investors. Anthropic planned up to 20% of the IPO shares for US retail accounts through platforms including Fidelity, Robinhood and Schwab, so ordinary investors could hold the stock from its first trade. So what did the founders say once the ticker was live?

What Dario Amodei Told the Market

Dario and Daniela Amodei, the siblings who co-founded Anthropic in 2021, marked the debut at the Nasdaq MarketSite in New York. Dario used the moment to talk about the whole field, not just his company's share price.

“The goal is to make the whole industry better, regardless of whether Anthropic is winning or losing at any given time.”— Dario Amodei

He also repeated the claim that defines Anthropic's pitch: that AI "could compress a century of medical and scientific progress into a decade." The filings give investors numbers to weigh it against. Revenue reached $33.2 billion in the first nine months of 2026, up 1,206% from a year earlier, and operating cash flow was a positive $6.6 billion, even as noncash charges pushed the period's net loss to $104 billion.

$107 Billion of Fresh Money

The IPO is only part of the haul. Alongside it, Anthropic is raising about $26 billion in a private placement from companies including AMD, Broadcom, Google, Microsoft and Nvidia, bringing the new money to about $107 billion. Its filings list about $900 billion of spending commitments through 2045, most of it for computing power.

The founders keep 50.1% of the voting power on general shareholder matters, so public investors are buying into a company whose direction stays in the hands that built it. What they get in return is a daily price for the most closely watched lab in AI, one anyone with a brokerage account can now check.

Five years after a seven-person founding team left OpenAI, a share of Anthropic opened at $111.50, and the bet on safety-first AI now has a public scoreboard.

Anthropic's First Day on Nasdaq

A visual summary of this story

The Brief

Stay curious

AI and technology: what changes and why it matters.
Your daily selection, in English or Spanish.

Free forever. Unsubscribe anytime.

Conversation

Start the conversation

No account needed. Comments are checked automatically — keep it civil.

More stories

Keep reading